Los Angeles, Sept. 18, 2014 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces the opening of a Start Fresh Recovery clinic in Atlanta, GA by Dr. George Fallieras. The clinic was opened through a distribution agreement with Dr. Fallieras, medical director of Start Fresh Recovery, who has appeared on the Emmy Award-winning show The Doctors. "We are pleased that this clinic will now be open, as Atlanta is a major hub in the Southeast. It opens up the opportunity to help many patients with our Start Fresh Program in this heavily populated region," stated CEO Kent Emry. The clinic is located at 3193 Howell Mill Road Suite 104, Atlanta, GA 30327 and will begin accepting consultations this Monday.
Expansion into Atlanta is a sensible strategic maneuver for the Company as the Atlanta Metropolitan area is the second largest in the Southeast consisting of 39 counties with an estimated population of 6.1 million people. Atlanta is also centrally located in the Southeast region of the country making it easily accessible to potential patients in nearby states and municipalities until more expansion occurs in the region.
According to MADD, Georgia recently saw an 11% uptick in drunk driving fatalities costing taxpayers an annual $1.47 Billion. The number of drug overdose deaths in Georgia, the majority of which are due to prescription drug abuse, has tripled since 1999. Street heroine has remained steadily available in Georgia through The Port of Savannah, which has long been a target of traffickers from outside the US.
About BioCorRx, Inc.
BioCorRx, Inc. (OTCQB: BICX) is an addiction treatment and rehabilitation company on the leading edge of substance abuse addiction treatment. The company has developed a highly effective program called the Start Fresh ProgramTM consisting of two components used by various addiction clinics in the US. Clinic reports show that the treatment program has an extremely high success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions. For more information on BICX, visit www.BioCorRx.com
Safe Harbor Statement
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.
CONTACT: Investor Relations SmallCapVoice.com, Inc. 512-267-2430